These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29086459)

  • 21. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
    Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH
    Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.
    Roberts AW; Foote S; Alexander WS; Scott C; Robb L; Metcalf D
    Blood; 1997 Apr; 89(8):2736-44. PubMed ID: 9108391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
    Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
    J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human granulocyte colony-stimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor.
    Yang FC; Watanabe S; Tsuji K; Xu MJ; Kaneko A; Ebihara Y; Nakahata T
    Blood; 1998 Dec; 92(12):4632-40. PubMed ID: 9845529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.
    Yan XQ; Hartley C; McElroy P; Chang A; McCrea C; McNiece I
    Blood; 1995 May; 85(9):2303-7. PubMed ID: 7537109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
    Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
    Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant granulocyte-macrophage colony-stimulating factor improves hematopoietic recovery after 5-fluorouracil.
    O'Reilly M; Gamelli RL
    J Surg Res; 1988 Jul; 45(1):104-11. PubMed ID: 3292840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor.
    Bodine DM; Seidel NE; Gale MS; Nienhuis AW; Orlic D
    Blood; 1994 Sep; 84(5):1482-91. PubMed ID: 7520774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.
    Neipp M; Zorina T; Domenick MA; Exner BG; Ildstad ST
    Blood; 1998 Nov; 92(9):3177-88. PubMed ID: 9787154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
    Patchen ML; MacVittie TJ; Solberg BD; Souza LM
    Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
    Moore MA; Stolfi RL; Martin DS
    J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice.
    Pospíŝil M; Hofer M; Znojil V; Vácha J; Netíková J; Holá J
    Blood; 1995 Nov; 86(10):3692-7. PubMed ID: 7579335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.
    Neben S; Marcus K; Mauch P
    Blood; 1993 Apr; 81(7):1960-7. PubMed ID: 7681707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A semiquinone glucoside derivative isolated from Bacillus sp. INM-1 provides protection against 5-fluorouracil-induced immunotoxicity.
    Mishra S; Malhotra P; Gupta AK; Singh PK; Javed S; Kumar R
    J Immunotoxicol; 2015; 12(1):56-63. PubMed ID: 24512327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.